Hypometabolism in Posterior and Temporal Areas of the Brain is Associated with Cognitive Decline in Parkinson's Disease.
Identifieur interne : 000433 ( PubMed/Corpus ); précédent : 000432; suivant : 000434Hypometabolism in Posterior and Temporal Areas of the Brain is Associated with Cognitive Decline in Parkinson's Disease.
Auteurs : Céline Tard ; Franck Demailly ; Arnaud Delval ; Franck Semah ; Luc Defebvre ; Kathy Dujardin ; Caroline MoreauSource :
- Journal of Parkinson's disease [ 1877-718X ] ; 2015.
English descriptors
- KwdEn :
- Brain (diagnostic imaging), Brain (metabolism), Cognition Disorders (complications), Cognition Disorders (diagnostic imaging), Cognition Disorders (metabolism), Fluorodeoxyglucose F18, Humans, Mental Status Schedule, Parkinson Disease (complications), Parkinson Disease (diagnostic imaging), Parkinson Disease (metabolism), Positron-Emission Tomography, Temporal Lobe (diagnostic imaging), Temporal Lobe (metabolism).
- MESH :
- chemical : Fluorodeoxyglucose F18.
- complications : Cognition Disorders, Parkinson Disease.
- diagnostic imaging : Brain, Cognition Disorders, Parkinson Disease, Temporal Lobe.
- metabolism : Brain, Cognition Disorders, Parkinson Disease, Temporal Lobe.
- Humans, Mental Status Schedule, Positron-Emission Tomography.
Abstract
Brain metabolic profiles of patients with Parkinson's disease (PD) and cognitive impairment or dementia are now available. It would be useful if data on brain metabolism were also predictive of the risk of a pejorative cognitive evolution - especially in the multidisciplinary management of advanced PD patients.
DOI: 10.3233/JPD-150583
PubMed: 26406137
Links to Exploration step
pubmed:26406137Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Hypometabolism in Posterior and Temporal Areas of the Brain is Associated with Cognitive Decline in Parkinson's Disease.</title><author><name sortKey="Tard, Celine" sort="Tard, Celine" uniqKey="Tard C" first="Céline" last="Tard">Céline Tard</name><affiliation><nlm:affiliation>Université de Lille, Lille, France.</nlm:affiliation></affiliation></author><author><name sortKey="Demailly, Franck" sort="Demailly, Franck" uniqKey="Demailly F" first="Franck" last="Demailly">Franck Demailly</name><affiliation><nlm:affiliation>Service de médecine nucléaire, CHRU Lille, Lille, France.</nlm:affiliation></affiliation></author><author><name sortKey="Delval, Arnaud" sort="Delval, Arnaud" uniqKey="Delval A" first="Arnaud" last="Delval">Arnaud Delval</name><affiliation><nlm:affiliation>Université de Lille, Lille, France.</nlm:affiliation></affiliation></author><author><name sortKey="Semah, Franck" sort="Semah, Franck" uniqKey="Semah F" first="Franck" last="Semah">Franck Semah</name><affiliation><nlm:affiliation>Université de Lille, Lille, France.</nlm:affiliation></affiliation></author><author><name sortKey="Defebvre, Luc" sort="Defebvre, Luc" uniqKey="Defebvre L" first="Luc" last="Defebvre">Luc Defebvre</name><affiliation><nlm:affiliation>Université de Lille, Lille, France.</nlm:affiliation></affiliation></author><author><name sortKey="Dujardin, Kathy" sort="Dujardin, Kathy" uniqKey="Dujardin K" first="Kathy" last="Dujardin">Kathy Dujardin</name><affiliation><nlm:affiliation>Université de Lille, Lille, France.</nlm:affiliation></affiliation></author><author><name sortKey="Moreau, Caroline" sort="Moreau, Caroline" uniqKey="Moreau C" first="Caroline" last="Moreau">Caroline Moreau</name><affiliation><nlm:affiliation>Université de Lille, Lille, France.</nlm:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2015">2015</date><idno type="RBID">pubmed:26406137</idno><idno type="pmid">26406137</idno><idno type="doi">10.3233/JPD-150583</idno><idno type="wicri:Area/PubMed/Corpus">000433</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000433</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Hypometabolism in Posterior and Temporal Areas of the Brain is Associated with Cognitive Decline in Parkinson's Disease.</title><author><name sortKey="Tard, Celine" sort="Tard, Celine" uniqKey="Tard C" first="Céline" last="Tard">Céline Tard</name><affiliation><nlm:affiliation>Université de Lille, Lille, France.</nlm:affiliation></affiliation></author><author><name sortKey="Demailly, Franck" sort="Demailly, Franck" uniqKey="Demailly F" first="Franck" last="Demailly">Franck Demailly</name><affiliation><nlm:affiliation>Service de médecine nucléaire, CHRU Lille, Lille, France.</nlm:affiliation></affiliation></author><author><name sortKey="Delval, Arnaud" sort="Delval, Arnaud" uniqKey="Delval A" first="Arnaud" last="Delval">Arnaud Delval</name><affiliation><nlm:affiliation>Université de Lille, Lille, France.</nlm:affiliation></affiliation></author><author><name sortKey="Semah, Franck" sort="Semah, Franck" uniqKey="Semah F" first="Franck" last="Semah">Franck Semah</name><affiliation><nlm:affiliation>Université de Lille, Lille, France.</nlm:affiliation></affiliation></author><author><name sortKey="Defebvre, Luc" sort="Defebvre, Luc" uniqKey="Defebvre L" first="Luc" last="Defebvre">Luc Defebvre</name><affiliation><nlm:affiliation>Université de Lille, Lille, France.</nlm:affiliation></affiliation></author><author><name sortKey="Dujardin, Kathy" sort="Dujardin, Kathy" uniqKey="Dujardin K" first="Kathy" last="Dujardin">Kathy Dujardin</name><affiliation><nlm:affiliation>Université de Lille, Lille, France.</nlm:affiliation></affiliation></author><author><name sortKey="Moreau, Caroline" sort="Moreau, Caroline" uniqKey="Moreau C" first="Caroline" last="Moreau">Caroline Moreau</name><affiliation><nlm:affiliation>Université de Lille, Lille, France.</nlm:affiliation></affiliation></author></analytic><series><title level="j">Journal of Parkinson's disease</title><idno type="eISSN">1877-718X</idno><imprint><date when="2015" type="published">2015</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Brain (diagnostic imaging)</term><term>Brain (metabolism)</term><term>Cognition Disorders (complications)</term><term>Cognition Disorders (diagnostic imaging)</term><term>Cognition Disorders (metabolism)</term><term>Fluorodeoxyglucose F18</term><term>Humans</term><term>Mental Status Schedule</term><term>Parkinson Disease (complications)</term><term>Parkinson Disease (diagnostic imaging)</term><term>Parkinson Disease (metabolism)</term><term>Positron-Emission Tomography</term><term>Temporal Lobe (diagnostic imaging)</term><term>Temporal Lobe (metabolism)</term></keywords><keywords scheme="MESH" type="chemical" xml:lang="en"><term>Fluorodeoxyglucose F18</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Cognition Disorders</term><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="diagnostic imaging" xml:lang="en"><term>Brain</term><term>Cognition Disorders</term><term>Parkinson Disease</term><term>Temporal Lobe</term></keywords><keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>Brain</term><term>Cognition Disorders</term><term>Parkinson Disease</term><term>Temporal Lobe</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Humans</term><term>Mental Status Schedule</term><term>Positron-Emission Tomography</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Brain metabolic profiles of patients with Parkinson's disease (PD) and cognitive impairment or dementia are now available. It would be useful if data on brain metabolism were also predictive of the risk of a pejorative cognitive evolution - especially in the multidisciplinary management of advanced PD patients.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26406137</PMID><DateCreated><Year>2015</Year><Month>09</Month><Day>26</Day></DateCreated><DateCompleted><Year>2016</Year><Month>07</Month><Day>21</Day></DateCompleted><DateRevised><Year>2016</Year><Month>11</Month><Day>25</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1877-718X</ISSN><JournalIssue CitedMedium="Internet"><Volume>5</Volume><Issue>3</Issue><PubDate><Year>2015</Year></PubDate></JournalIssue><Title>Journal of Parkinson's disease</Title><ISOAbbreviation>J Parkinsons Dis</ISOAbbreviation></Journal><ArticleTitle>Hypometabolism in Posterior and Temporal Areas of the Brain is Associated with Cognitive Decline in Parkinson's Disease.</ArticleTitle><Pagination><MedlinePgn>569-74</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3233/JPD-150583</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Brain metabolic profiles of patients with Parkinson's disease (PD) and cognitive impairment or dementia are now available. It would be useful if data on brain metabolism were also predictive of the risk of a pejorative cognitive evolution - especially in the multidisciplinary management of advanced PD patients.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The primary objective was to determine whether a specific brain metabolic pattern is associated with cognitive decline in PD.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Sixteen advanced PD patients were screened for the absence of cognitive impairment (according to the Mattis dementia rating scale, MDRS) and underwent [18F]-fluorodeoxyglucose positron emission tomography brain imaging in the "off drug" state. The MDRS was scored again about two years later, categorizing patients as having significant cognitive decline (decliners) or not (stables). The two groups were then compared in terms of their brain metabolism at inclusion.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">There were six decliners and ten stables. Significant hypometabolism in the two precunei (Brodmann area (BA) 31), the left middle temporal gyrus (BA21) and the left fusiform gyrus (BA37) was found in the decliner group compared withthe stables.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">In advanced PD, a particular metabolic pattern may be associated with the onset of significant cognitive decline.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tard</LastName><ForeName>Céline</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Université de Lille, Lille, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>INSERM U1171, Lille, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Service de neurophysiologie clinique, CHRU Lille, Lille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Demailly</LastName><ForeName>Franck</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Service de médecine nucléaire, CHRU Lille, Lille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Delval</LastName><ForeName>Arnaud</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Université de Lille, Lille, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>INSERM U1171, Lille, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Service de neurophysiologie clinique, CHRU Lille, Lille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Semah</LastName><ForeName>Franck</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Université de Lille, Lille, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>INSERM U1171, Lille, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Service de médecine nucléaire, CHRU Lille, Lille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Defebvre</LastName><ForeName>Luc</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Université de Lille, Lille, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>INSERM U1171, Lille, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Service de neurologie et pathologie du mouvement, CHRU Lille, Lille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dujardin</LastName><ForeName>Kathy</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Université de Lille, Lille, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>INSERM U1171, Lille, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Service de neurologie et pathologie du mouvement, CHRU Lille, Lille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moreau</LastName><ForeName>Caroline</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Université de Lille, Lille, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>INSERM U1171, Lille, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Service de neurologie et pathologie du mouvement, CHRU Lille, Lille, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Parkinsons Dis</MedlineTA><NlmUniqueID>101567362</NlmUniqueID><ISSNLinking>1877-7171</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0Z5B2CJX4D</RegistryNumber><NameOfSubstance UI="D019788">Fluorodeoxyglucose F18</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003072" MajorTopicYN="N">Cognition Disorders</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019788" MajorTopicYN="N">Fluorodeoxyglucose F18</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008609" MajorTopicYN="N">Mental Status Schedule</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D049268" MajorTopicYN="N">Positron-Emission Tomography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013702" MajorTopicYN="N">Temporal Lobe</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>9</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>9</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>7</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26406137</ArticleId><ArticleId IdType="pii">JPD150583</ArticleId><ArticleId IdType="doi">10.3233/JPD-150583</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000433 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000433 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonFranceV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:26406137
|texte= Hypometabolism in Posterior and Temporal Areas of the Brain is Associated with Cognitive Decline in Parkinson's Disease.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:26406137" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a ParkinsonFranceV1
| This area was generated with Dilib version V0.6.29. |  |